Department of Pharmacy, Northwestern Medicine, Chicago, IL, USA.
Department of Pharmacy, Oregon Health & Science University, Portland OR, USA.
Am J Health Syst Pharm. 2021 Jun 7;78(12):1104-1111. doi: 10.1093/ajhp/zxab114.
The coronavirus disease 2019 (COVID-19) pandemic has impacted the activities of healthcare workers, including postgraduate pharmacy trainees. Quality training experiences must be maintained to produce competent pharmacy practitioners and maintain program standards.
A cross-sectional survey of postgraduate pharmacy trainees in the United States was conducted to evaluate training experience changes and assess perceived impacts on residents and fellows following the COVID-19 pandemic's onset.
From June 4 through June 22, 2020, 511 pharmacy trainees in 46 states completed the survey. Participants' median age was 26 (interquartile range [IQR], 25-28) years, with included responses from postgraduate year 1 residents (54% of sample), postgraduate year 2 residents (40%), and postgraduate fellows (6%). Compared to experiences prior to the onset of the COVID-19 pandemic, fewer trainees conducted direct patient care (38.5% vs 91.4%, P < 0.001), more worked from home (31.7% vs 1.6%, P < 0.001), and less time was spent with preceptors per day (2 [IQR, 2-6] hours vs 4 [IQR, 1-4] hours, P < 0.001). Sixty-five percent of respondents reported experiencing changes in their training program, 39% reported being asked to work in areas outside of their routine training experience, and 89% stated their training shifted to focus on COVID-19 to some degree. Most respondents perceived either major (9.6%) or minor (52.0%) worsening in quality of experience, with major and minor improvement in quality of experience reported by 5.5% and 8.4% of respondents, respectively.
Pharmacy resident/fellow experiences were perceived to have been extensively impacted by the COVID-19 pandemic in varying ways. Our findings describe shifts in postgraduate training and may aid in the development of best practices for optimizing trainee experiences in future crises.
2019 年冠状病毒病(COVID-19)大流行影响了医护人员的活动,包括研究生药学实习生。必须保持高质量的培训经验,以培养有能力的药学从业人员并维持项目标准。
对美国的研究生药学实习生进行了横断面调查,以评估 COVID-19 大流行爆发后培训经验的变化,并评估对住院医师和研究员的影响。
2020 年 6 月 4 日至 6 月 22 日,来自 46 个州的 511 名药学实习生完成了调查。参与者的中位年龄为 26 岁(四分位距[IQR],25-28 岁),包括研究生第 1 年住院医师(样本的 54%)、研究生第 2 年住院医师(40%)和研究生研究员(6%)的回复。与 COVID-19 大流行前的经验相比,进行直接患者护理的实习生人数减少(38.5%比 91.4%,P<0.001),更多的人在家工作(31.7%比 1.6%,P<0.001),并且每天与导师相处的时间减少(2[IQR,2-6]小时比 4[IQR,1-4]小时,P<0.001)。65%的受访者报告说培训计划发生了变化,39%的受访者报告说被要求从事常规培训经验以外的工作,89%的受访者表示培训在一定程度上转向了 COVID-19。大多数受访者认为经验质量要么有很大(9.6%),要么有较小(52.0%)的恶化,5.5%和 8.4%的受访者分别报告经验质量有较大和较小的改善。
住院医师/研究员的经验被认为受到 COVID-19 大流行的广泛影响,方式各不相同。我们的研究结果描述了研究生培训的转变,并可能有助于为未来危机中优化实习生经验制定最佳实践。